The human body is an incredibly complex and amazing entity. No two people are exactly alike because no two people have identical DNA. DNA is the building block for humans, and something seemingly so simple as a double helix has the ability to control all of our genetic programming. Recently technology has helped us begin to unlock the secrets DNA has encoded, and our ability to understand the human genome has greatly expanded. The company at the forefront of this life sciences industry is Illumina.
Illumina is committed to unlocking the human genome to transform healthcare and beyond. “This field as dramatic growth potential and the ability to transform people’s lives. Currently, Illumina develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and function. It provides a comprehensive line of genetic analysis solutions with products and services that serve a broad range of highly interconnected markets, including sequencing, genotyping, gene expression and molecular diagnostics.” (http://www.forbes.com/companies/illumina/) Operating in two segments, Life Sciences and Diagnostics, Illumina is able to provide products and services for the research market and research in the molecular diagnostics field. Their ability to develop, manufacture and sell integrated systems for the analysis of genetic variation and biological function is making a difference in human health.
A global leader in genomics, Illumina says on their website they are at the intersection of biology and technology. Their simple description for what they do is “At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable.” (http://www.illumina.com/company/about-us.html) They are a forward looking company, and will help medicine to become increasingly preventative and more precise. Humans will be healthier and live longer.
Illumina is a rare company clearly doing good for society and generating value for shareholders. This combination makes them a company I admire and I am excited to see what the future holds for them.